Neuromuscular disease: Muscular dystrophy-something new on God's green earth?

Nature Reviews Neurology

Volumn 8, Issue 5, 2012, Pages 247-249

  Ferlini, Alessandra ^a  

^a UNIVERSITY OF FERRARA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE KINASE;

COST BENEFIT ANALYSIS; DRIED BLOOD SPOT TESTING; DUCHENNE MUSCULAR DYSTROPHY; EARLY DIAGNOSIS; EMOTIONAL STRESS; GENE MUTATION; GENETIC SCREENING; INFORMED CONSENT; MEDICAL ETHICS; MENTAL STRESS; NEWBORN SCREENING; PARENTAL ATTITUDE; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; REVIEW;

GENETIC TESTING; HUMANS; INFANT, NEWBORN; MUSCULAR DYSTROPHIES; NEONATAL SCREENING;

EID: 84860889735     PISSN: 17594758     EISSN: 17594766     Source Type: Journal    
DOI: 10.1038/nrneurol.2012.41     Document Type: Review

References (10)

1. Mendell, J. R. et al. Evidence based path to newborn screening for Duchenne muscular dystrophy. Ann. Neurol. http://dx.doi.org/10.1002/ana.23528.
2. Bowman, J. E. Screening newborn infants for Duchenne Muscular dystrophy. BMJ 306, 349 (1993). (Pubitemid 23039389)
3. Parsons, E. P., Bradley, D. M. & Clarke, A. J. Newborn screening for Duchenne muscular dystrophy. Arch. Dis. Child. 88, 91-92 (2003). (Pubitemid 36098983)
4. Elliman, D. A., Dezateux, C. & Bedford, H. E. Newborn and childhood screening programmes: criteria, evidence, and current policy. Arch. Dis. Child. 87, 6-9 (2002). (Pubitemid 34753762)
5. Kemper, A. R. & Wake, M. A. Duchenne muscular dystrophy: issues in expanding newborn screening. Curr. Opin. Pediatr. 19, 700-704 (2007). (Pubitemid 350145241)
6. rd, Pandya, S., Ciafaloni, E., Fox, D. J. & Campbell, K. Change in natural history of Duchenne muscular dystrophy with long-term corticosteroid treatment: implications for management. J. Child. Neurol. 25, 1116-1129 (2010).
7. Hennekam, R. C. Care for patients with ultra-rare disorders. Eur. J. Med. Genet. 54, 220-224 (2011).
8. Campbell, E. & Ross, L. F. Parental attitudes regarding newborn screening of PKU and DMD. Am. J. Med. Genet. A. 120A, 209-214 (2003). (Pubitemid 37063798)
9. Pollitt, R. J. New technologies extend the scope of newborn blood-spot screening, but old problems remain unresolved. Acta Paediatr. 99, 1766-1772 (2010).
10. Elliman, D. Ethical aspects of the expansion of neonatal screening programme due to technological advances. Clin. Chem. Lab. Med. http://dx.doi.org/10.1515/cclm.2011.761.